2003 - Fellow of the American Association for the Advancement of Science (AAAS)
His research on Schizophrenia (object-oriented programming) often connects related topics like Antipsychotic. With his scientific publications, his incorporates both Antipsychotic and Psychosis. In his works, Michael A. Caligiuri performs multidisciplinary study on Psychosis and Parkinsonism. He conducts interdisciplinary study in the fields of Parkinsonism and Dopamine through his research. While working on this project, Michael A. Caligiuri studies both Dopamine and Dopaminergic. As part of his studies on Dopaminergic, he frequently links adjacent subjects like Neuroscience. His study ties his expertise on Central nervous system together with the subject of Neuroscience. Borrowing concepts from Basal ganglia, he weaves in ideas under Central nervous system. His research on Basal ganglia frequently links to adjacent areas such as Internal medicine.
His research links Clinical trial with Internal medicine. His study brings together the fields of Internal medicine and Clinical trial. He conducted interdisciplinary study in his works that combined Disease and Risk factor. Michael A. Caligiuri undertakes multidisciplinary investigations into Risk factor and Disease in his work. With his scientific publications, his incorporates both Psychiatry and Pediatrics. In his research, Michael A. Caligiuri performs multidisciplinary study on Pediatrics and Psychiatry. His research on Schizophrenia (object-oriented programming) often connects related topics like Tardive dyskinesia. Michael A. Caligiuri undertakes interdisciplinary study in the fields of Tardive dyskinesia and Antipsychotic through his research. His work on Schizophrenia (object-oriented programming) expands to the thematically related Antipsychotic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.
T. R. Golub;T. R. Golub;D. K. Slonim;P. Tamayo;C. Huard.
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Tsvee Lapidot;Christian Sirard;Josef Vormoor;Barbara Murdoch.
The biology of human natural killer-cell subsets.
Megan A Cooper;Todd A Fehniger;Michael A Caligiuri.
Trends in Immunology (2001)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier;David H. Raulet;Alessandro Moretta;Michael A. Caligiuri.
Human natural killer cells
Michael A. Caligiuri.
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
Joseph F. Costello;Joseph F. Costello;Michael C. Frühwald;Michael C. Frühwald;Dominic J. Smiraglia;Laura J. Rush.
Nature Genetics (2000)
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Megan A. Cooper;Todd A. Fehniger;Sarah C. Turner;Kenneth S. Chen.
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Muller Fabbri;Alessio Paone;Federica Calore;Roberta Galli.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
William E. Carson;Judith G. Giri;Matthew J. Lindemann;Michael L. Linett.
Journal of Experimental Medicine (1994)
Interleukin 15: biology and relevance to human disease
Todd A. Fehniger;Michael A. Caligiuri.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: